| Ref-No. | Technology |
| PLA15A18 | TUBiRA: First-in-class TRAF6-Ubc13 inhibitors for treatment of Rheumatoid Arthritis |
| PLA18A03 | GDzyme: A New Biotherapeutic for Asthma and Allergy |
| PLA18A06 | ComboMiR: combinatorial microRNA Therapeutics for Diabetic Complications |
| PLA21A28 | Novel inhibitors of ferroptosis suppressor protein-1 (FSP1) as anticancer therapy |
| PLA22A20 | iQFerr Therapeutics: Quinone-based anti-ferroptotic drugs for the treatment of organ damage and neurodegeneration |
| PLA22A26 | TRAF2:LMP1 small molecule inhibitors for the treatment of Epstein-Barr virus-induced cancer |
| 01-00986 | Non-invasive and high-throughput monitoring of exon-specific isoform expression |
| 01-00988 | INSPECT – Intron encoded reporter transcripts for minimally invasive monitoring of coding and non-coding RNAs |
| 01-01036 | Novel therapy approach for treatment of lung fibrosis |
| 01-01080 | Drug combinations to overcome therapy resistance in cancer |
| 01-01085 | Expansion of pancreatic progenitors derived from human pluripotent stem cells und GMP-compliant conditions |
